Citadel Advisors’s POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO XLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-14,912
Closed -$1.19M 8676
2017
Q1
$1.19M Sell
14,912
-33,316
-69% -$2.66M ﹤0.01% 3760
2016
Q4
$3.53M Buy
48,228
+39,043
+425% +$2.86M ﹤0.01% 2338
2016
Q3
$684K Buy
9,185
+5,464
+147% +$407K ﹤0.01% 4369
2016
Q2
$263K Sell
3,721
-45,673
-92% -$3.23M ﹤0.01% 5422
2016
Q1
$3.27M Buy
49,394
+32,241
+188% +$2.13M ﹤0.01% 2176
2015
Q4
$1.23M Sell
17,153
-30,249
-64% -$2.17M ﹤0.01% 3323
2015
Q3
$3.08M Buy
47,402
+43,225
+1,035% +$2.81M ﹤0.01% 2433
2015
Q2
$297K Buy
+4,177
New +$297K ﹤0.01% 5760

Other funds holding XLVS

Citadel Advisors's XLVS Position: Q2 2017 in Review

Citadel Advisors sold out of POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO (XLVS) in Q2 2017, closing a stake of 14,912 shares — an estimated $1.19M sold.

Citadel Advisors first reported a position in XLVS in Q2 2015 and held it in 8 quarters. The position peaked at $3.53M in Q4 2016. 55 funds tracked by Wall St. Rank hold XLVS as of Q2 2017.

  • Citadel Advisors reported no remaining POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO position as of Q2 2017 after selling out during the quarter.
  • Citadel Advisors sold 14,912 POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO shares in Q2 2017, an estimated $1.19M.
  • Citadel Advisors first reported a position in POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO in Q2 2015 and held it in 8 quarters.
  • Citadel Advisors's POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO position peaked at $3.53M in Q4 2016.
  • 55 funds tracked by Wall St. Rank held POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO as of Q2 2017.

Based on Citadel Advisors's 13F filing for Q2 2017, filed 11 Aug 2017.